English

RAISIO GROUP'S PUBLIC OFFER WIDELY ACCEP

Report this content 
Raisio Group plc           Stock Exchange Release
                           31 March 2003 at 9.00 Finnish time


RAISIO GROUP’S PUBLIC OFFER WIDELY ACCEPTED;
DIFFCHAMB TO BECOME A SUBSIDIARY FROM THE BEGINNING OF APRIL

Raisio Group has placed a public offer to acquire all shares in
Diffchamb AB, which is listed on the O-list of Stockholm Stock
Exchange. During the acceptance period 6 March to 26 March 2003
shareholders representing approximately 96.6 per cent of Diffchamb
shares have accepted the offer.

Cash settlement will commence on or about 3 April, which means
that Diffchamb AB will be consolidated into Raisio Group figures
from the beginning of the second quarter. The purchase price for
the 96.6 per cent is approximately EUR 16.6 million.

The final acceptance date in the offer will be extended to 9 April
2003. Furthermore, Raisio will initiate a de-listing of the
Diffchamb shares from the Stockholm Exchange at the earliest
convenience.

Diffchamb is an international biotechnology company involved in
development, manufacturing and sales of equipment for foodstuff
testing. Diffchamb is specialised in rapid and efficient analysis
methods based on modern technology. Diffchamb’s turnover for 2002
amounted to about EUR 13 million and profit before taxes to EUR
520,000. The number of employees was approximately 100 at the end
of 2002. More info can be found at www.diffchamb.com.

The strategic goal for Raisio Life Sciences is to expand its
business into food and animal feed diagnostics. The acquisition of
Diffchamb provides Raisio Life Sciences an excellent platform to
build a strong global food diagnostics business.

RAISIO GROUP PLC


Taru Narvanmaa
Executive Vice President, Communications and IR
+ 358 50 590 9398

Further information:
Jukka Lavi
President, Raisio Life Sciences
tel. +358 40 544 3280

Subscribe